Background and Aim: Endoscopic papillary large balloon dilation (EPLBD) without endoscopic sphincterotomy (EST) may facilitate extraction of large bile duct stones through achieving adequate dilation of the ampulla. However, contrary to favorable long-term outcomes after endoscopic papillary balloon dilation (EPBD), that of EPLBD without EST has been little investigated. Therefore, we conducted the current study to evaluate short-and long-term outcomes of EPLBD without EST and EPBD after removal of large bile duct stones (LBDS; ≥10 mm).
INTRODUCTION

E
NDOSCOPIC SPHINCTEROTOMY (EST) is widely accepted as a standard technique for the removal of bile duct stones during endoscopic retrograde cholangiopancreatography (ERCP). [1] [2] [3] Endoscopic papillary balloon dilation (EPBD) is a possible alternative to EST in cases of coagulopathy (e.g. patients with liver cirrhosis, on antithrombotic agents or on dialysis) because of its low risk of hemorrhage. [4] [5] [6] [7] [8] [9] [10] [11] Another advantage of EPBD is its lower rate of late biliary events as a result of preservation of the sphincter of Oddi. [12] [13] [14] [15] [16] [17] However, in addition to a risk of post-ERCP pancreatitis (PEP), [18] [19] [20] [21] EPBD has a disadvantage during extraction of large bile duct stones (LBDS). Although, the use of mechanical lithotripsy (ML) is a possible risk factor for late biliary events after EPBD, 22, 23 ML is more often necessary after EPBD compared with EST for removal of LBDS.
Recently, efficacy and safety of endoscopic papillary large balloon dilation (EPLBD) were reported for removal of LBDS. [24] [25] [26] [27] [28] Although EST is often carried out prior to EPLBD, EPLBD without EST also reported similar short-term results to EPLBD with EST. [29] [30] [31] [32] The potential advantage of EPLBD without EST over EPLBD with EST is a low risk of hemorrhage or perforation, lower cost, shorter procedure time, and possibility of preservation of sphincter function. However, long-term outcomes after EPLBD without EST have been little investigated. [32] [33] [34] [35] [36] Therefore, we conducted this retrospective study to compare short-and long-term outcomes of EPLBD without EST and EPBD after endoscopic removal of LBDS. Propensity scorebased matching analysis was carried out to mitigate bias due to potential confounders.
METHODS
Study design
T HIS IS A single-center, matched cohort analysis to compare short-term and long-term outcomes of EPLBD without EST and EPBD for removal of LBDS. Consecutive data on patients undergoing endoscopic treatment of LBDS at The University of Tokyo were retrospectively collected from our prospectively collected database and hospital medical records. Written informed consent was obtained from each patient before the procedure. This study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the ethics committee at The University of Tokyo Hospital.
Patients
Patients without a previous history of EST, EPBD or EPLBD who underwent EPLBD without EST or EPBD for removal of LBDS (≥10 mm) between November 1994 and April 2017 were included in this study. Exclusion criteria were as follows: (i) patients with Billroth-II or Roux-en-Y reconstruction; (ii) patients who underwent EPLBD with EST; (iii) patients with acute pancreatitis; and (iv) patients who were lost to follow up within 30 days after discharge. Primary outcome of this study was late biliary complications (>30 days). Secondary outcomes were rate of complete stone removal in a single session, number of ERCP sessions for complete stone removal, rate of lithotripsy use, and early adverse events.
Endoscopic procedures
After obtaining cholangiogram and confirming the presence of bile duct stones, diameter of the distal bile duct was measured on the cholangiogram. In cases that underwent EPBD, a 6-to 10-mm balloon catheter (Eliminator; CONMED Japan, Tokyo, Japan, Hurricane TM RX; Boston Scientific Japan, Tokyo, Japan or ZARA; Century Medical, Tokyo, Japan) was used for balloon dilation. EPBD procedure was carried out as previously described. 7, 37 Briefly, ballooning time of EPBD was 2 min until June 1999, 5 min from July 2013 to September 2014, and 15 s in the other period (i.e., from July 1999 to June 2013 and from October 2014 until the present time).
EPLBD was introduced to our institution in March 2008. EPLBD without EST was carried out using a 12-to 20-mm balloon catheter (CRE wire-guided balloon dilator [12-15 mm, 15-18 mm or 18-20 mm]; Boston Scientific Japan or Giga [10-12, 13-15, 16-18 mm] ; Century Medical). The balloon was inflated gradually with diluted contrast medium under endoscopic and fluoroscopic guidance and was deflated immediately after the disappearance of the waist of the balloon. EPLBD or EPBD balloon size was selected according to the size of bile duct stones but did not exceed the diameter of the distal bile duct.
Stone extraction was carried out using a basket and/or retrieval balloon catheter. 38 When the stone diameter was larger than the size of the EPBD or EPLBD balloon and could not be removed without fragmentation, lithotripsy, either endoscopic mechanical lithotripsy (EML), electrohydraulic shockwave lithotripsy (EHL), extracorporeal shockwave lithotripsy (ESWL) or a combination, was carried out. If complete stone removal was not achieved within approximately 1 h, a biliary stent or a nasobiliary catheter was placed, and the residual stones were removed in the following sessions without repeating EPBD or EPLBD. Complete stone removal was confirmed using intraductal ultrasonography or balloon-occluded cholangiography.
Evaluation of early and late adverse events
All patients were hospitalized at least one night after ERCP to follow possible early adverse events. Hematological examinations, including complete blood count, liver function tests, pancreatic enzymes, and C-reactive protein level, were carried out 18-24 h after the procedure. Abdominal radiography, ultrasound, or computed tomography (CT) was done when needed. Early adverse events (within 30 days after the procedure) and their severity were defined according to the lexicon of the American Society of Gastrointestinal Endoscopy. 39 Patients with complete stone clearance were included in the analysis of long-term outcomes. Clinical symptoms (fever, abdominal pain, and jaundice), hematological examinations including liver function test, and abdominal ultrasound were followed every 3-6 months except in patients with poor performance status who could not visit the outpatient clinic. Pneumobilia, which is an indication for the loss of sphincter function, 16 was confirmed by abdominal ultrasound in the follow-up period. Bile duct stone recurrences were confirmed using abdominal CT, magnetic resonance cholangiopancreatography, and/or endoscopic ultrasonography. Cholangitis and cholecystitis as late adverse events were defined according to the current version of the Tokyo guidelines for the management of acute cholangitis and cholecystitis (Japanese Society of HepatoBiliary-Pancreatic Surgery). 40, 41 Propensity score matching
We carried out propensity score matching because betweengroup differences in baseline characteristics in the total cohort could influence our primary outcome. The propensity score of undergoing EPLBD without EST or EPBD was calculated using a multivariable logistic regression model. Bile duct diameter and gallbladder status were previously reported as risk factors for stone recurrence after EPLBD or EPBD. 22, 32, 33, 35, 36 Furthermore, number of stones could determine whether to carry out EPLBD or EPBD. Finally, differences in age and gender between the two groups in the total cohort should be matched. Taking this into account, the following characteristics of patients were included in the model: age (continuous), gender (female vs male), number of stones (continuous), bile duct diameter (continuous), gallbladder status (categorical: postcholecystectomy, cholecystectomy after removal of bile duct stones, gallbladder stones in situ or no gallbladder stones).
Subsequently, each patient in the EPLBD without EST group was matched to a patient in the EPBD group with the nearest-neighbor method using a caliper range of 0.25 of the standard deviation of the pooled propensity scores (i.e. 0.13 9 0.25 = 0.03).
Statistical analysis
Categorical variables were compared using the chi-squared test or Fisher's exact test as appropriate. Continuous variables were compared using the Wilcoxon rank-sum test. Cumulative rate of late biliary complications was estimated using the Kaplan-Meier method and compared using the log-rank test.
All statistical analyses and matching were carried out using EZR software (Saitama Medical Center, Jichi Medical University, Saitama, Japan), which is a graphical user interface for R software (The R Foundation for Statistical Computing, Vienna, Austria, version 3.4.1). More precisely, EZR is a modified version of R commander (version 2.4-0) that was designed to add statistical functions frequently used in biostatistics. 42 
RESULTS
A
TOTAL OF 307 patients without a previous history of EST or EPBD underwent EPLBD or EPBD for removal of LBDS from November 1994 to April 2017 (Fig. 1) , and 232 patients met the criteria of this study; 47 and 185 patients underwent EPLBD without EST or EPBD, respectively. Using the algorithm described above, 44 patients who underwent EPLBD without EST were successfully matched to 44 patients who underwent EPBD.
In the total cohort, baseline characteristics were statistically significantly different between the EPLBD without EST and EPBD groups in terms of gender and age. Propensity matching well balanced these differences between the two groups ( Table 1) . Details of EPBD and EPLBD balloons are also shown in Table 1 . Although the balloon size was 8 mm in 90% of the EPBD group, it was 12-14 mm in 61% of the matched EPLBD group.
Details of the procedure and early adverse events of ERCP are summarized in Table 2 . Complete stone removal during index hospitalization was achieved in 100% in both groups. Rate of complete stone removal in a single session was 80% in the matched EPLBD without EST group compared with 16% in the matched EPBD group (P < 0.001). Number of ERCP sessions and rate of lithotripsy use were statistically significantly smaller in the matched EPLBD without EST group (mean AE SD, 1.3 AE 0.7 vs 2.4 AE 1.5, P < 0.001, and 30% vs 80%, P < 0.001, respectively). Early adverse events did not differ significantly between the two groups (P = 0.99). Four PEP (9.1%) developed in each group (P = 0.99). There was one severe PEP with prolonged hospitalization (18 days) in the matched EPLBD without EST group, which improved with conservative treatment without any interventions. Although antithrombotics were given to 32% in the matched EPLBD without EST group and to 23% in the matched EPBD group (P = 0.47), neither group developed bleeding.
Late biliary complications are shown in Table 3 and Figure 2 . The follow-up period was statistically significantly shorter in the matched EPLBD without EST group (22 vs 58 months in the matched EPLBD without EST and EPBD group, P < 0.001). Overall late biliary complications occurred in nine (21%) in the matched EPLBD without EST group and three (6.8%) in the matched EPBD group (P = 0.12). Although one cholangitis, three cholecystitis, and one liver abscess developed as late complications in the matched EPLBD without EST group, there was no biliary tract infection as late complication in the matched EPBD group. Cumulative rates of late biliary complications in the matched EPLBD without EST and EPBD groups were 14% vs 4.5% at 1 year, and 16% vs 6.8% at 2 years (P = 0.02 by the log-rank test, Fig. 2 ). During the follow-up period, pneumobilia was observed in 53% in the matched EPLBD without EST group compared with 19% in the matched EPBD group (P = 0.006).
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DISCUSSION
T HIS RETROSPECTIVE PROPENSITY score-based matching study was conducted to evaluate the shortand long-term outcomes of EPLBD without EST and EPBD after endoscopic removal of LBDS. Rate of late biliary complications was higher in the matched EPLBD without EST group compared with the matched EPBD group. Regarding safety, EPLBD without EST did not increase early adverse events of ERCP compared to EPBD. Rate of lithotripsy use and number of ERCP sessions for complete stone removal were significantly lower, and rate of complete stone removal in a single session was higher in the matched EPLBD without EST group, suggesting its higher efficacy in removal of LBDS.
Cumulative rate of late biliary complications was statistically significantly higher in the matched EPLBD without EST group in this study. Recently, accumulating evidence suggests better long-term outcomes of EPBD compared to EST for endoscopic removal of small bile duct stones because of the preserved sphincter function. [15] [16] [17] EPLBD is considered to potentially preserve sphincter function and reduce late biliary complications by avoiding the preceding EST (Fig. 3) . However, in our study, the rate of pneumobilia was higher (53%) in the EPLBD group, suggesting impairment of sphincter of Oddi function 16 and, contrary to our assumption, we failed to show preferable longterm outcomes of EPLBD without EST. Despite the null events of biliary tract infection as late biliary complications in the matched EPBD group, 11% in the matched EPLBD without EST group developed cholangitis, cholecystitis, and liver abscess. Regular follow-up imaging studies carried out regardless of symptoms in our study cohort might increase late biliary complications, but the presence of pneumobilia is known to be associated with late biliary complications. 34 Although EPLBD without EST was associated with increased late biliary complications, it improved the rate of complete stone removal in a single session and reduced the rate of lithotripsy use and the number of ERCP sessions for complete stone removal. 28, 43 The lower use of EML did not reduce procedure time in a first session in the matched EPLBD without EST group. The increased rate of complete stone removal in a single session potentially prolongs procedure time. Despite the improved effectiveness of stone removal in EPLBD without EST which could reduce medical costs, early adverse events including PEP did not differ between the two groups. EPLBD is reportedly associated with a lower PEP rate compared with EPBD, 19, 44 contrary to our results in which the methods for PEP reduction (i.e. pancreatic stent placement and rectal NSAIDs) 45, 46 between the groups is comparative. Considering the association between narrow bile duct and PEP, 47 our study population with a large bile duct may have a low risk of PEP even after EPBD. In this study, all patients, including even those with null physical symptoms, were hospitalized after ERCP and underwent both physical examinations and blood tests. This strategy potentially increased PEP rate as a result of overestimation of mild pancreatitis.
Endoscopic papillary balloon dilation provided better long-term outcomes with fewer late biliary complications but cannot be a first-line treatment for LBDS given its lower effectiveness of stone removal. Young patients with LBDS who have longer life expectancy might gain benefits from EPBD, although most LBDS are diagnosed in elderly patients. Cholecystectomy should be carried out to reduce late biliary complications, but the risk of late biliary complications in patients with gallbladder left in situ after EPBD was relatively low in cases with a large bile duct or large bile duct stones. 48 In those cases, bile duct stones are likely to be primary stones rather than secondary stones that migrated from the gallbladder. Recurrence of primary bile duct stones is possible even after cholecystectomy, and it is still unclear whether or not cholecystectomy should be carried out in all cases with gallstones after endoscopic treatment of LBDS. 49 This should be confirmed in a largescale data study.
It still remains controversial whether or not EPLBD should be preceded by EST. Although short-term outcomes such as early adverse events and effectiveness of stone removal were reportedly not different between EPLBD with and without EST, 44, 50, 51 to date, there have been no comparative studies on the long-term outcomes of EPLBD with and without EST. Our study results suggested that long-term outcomes after EPLBD without EST appeared comparable to those of EPLBD with EST in the previous studies. 33, 35 Omission of EST prior to EPLBD might be simpler and more cost-effective, but there are some concerns about potential risks of PEP. Previous reports and guidelines did not suggest a higher incidence of PEP in EPLBD without EST compared to EPLBD with EST. 44, 51 In our study, PEP developed in Figure 2 Cumulative rates of late biliary complications using the Kaplan-Meier method. Small vertical bars on the graphs indicate censored cases. The cumulative rate was higher in the matched endoscopic papillary large balloon dilation (EPLBD) without endoscopic sphincterotomy (EST) group. EPBD, endoscopic papillary balloon dilation. EPLBD without EST, -----; EPBD, -----.
9.1% including one severe case, which appeared higher than in previous reports. [29] [30] [31] [32] 44 Although longer ballooning time decreased PEP during EPBD in the previous randomized controlled trial (RCT), 52 we did not find any differences between EPBD taking 5 min or EPBD taking 15 s to carry out, 37 and the effect of longer ballooning time during EPLBD is still controversial. 53 At least, EPLBD without EST could be indicated when EST is difficult or risky (i.e. in cases with coagulopathy or with surgically altered anatomy).
There were some limitations in the present study that should be acknowledged. First, it was a single-center, retrospective study and selection bias may exist. However, consecutive patients who underwent EPBD or EPLBD without EST for endoscopic removal of LBDS during the study period were included. Furthermore, propensity scorebased matching well balanced the baseline characteristics between the two groups. Second, the shorter follow-up period in the matched EPLBD without EST group was another limitation of this study. Nevertheless, prolonged follow-up period of the EPLBD without EST group could not alter the positive result in late biliary complications. Finally, a relatively small sample size limited the statistical power of this study. The one-to-two matching further decreased sample size in each group (leaving only 30 patients in the EPLBD without EST group), and failed to increase power. However, it is unlikely that EPLBD without EST would demonstrate fewer late biliary events and a future study should be focused on the population best fit for this procedure.
In conclusion, EPLBD without EST for endoscopic removal of LBDS allowed a high single-session success rate, but might be associated with a higher cumulative incidence of late biliary complications compared to EPBD. The role of EPLBD without EST as compared to EST, EPBD, and EPLBD with EST is yet to be determined. 
